Surgical treatment for progressive prostate cancer: A clinical case
https://doi.org/10.17650/1726-9776-2014-10-3-95-99
Abstract
In spite of its existing standards, the treatment of patients with progressive prostate cancer (PC) remains a matter of debate. Ensuring that the patients have good quality of life is also relevant. The paper describes a clinical case of a patient with progressive PC after hormone therapy, brachytherapy, salvage prostatectomy, enucleation of the testicular parenchyma, and salvage lymphadenectomy. A phallic prosthesis and an artificial urinary sphincter have been implanted to improve quality of life. The results of preoperative examination and the technological features of surgical interventions are given.
About the Authors
E. I. Veliev
Department of Urology and Surgical Andrology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
E. N. Golubtsova
Department of Urology and Surgical Andrology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
A. A. Tomilov
Department of Urology and Surgical Andrology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
References
1. Center M.M., Jemal A., Lortet-Tieulent J. et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012;61:1079–92.
2. Cooperberg M.R., Broering J.M., Carroll P.R. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010;28: 1117–23.
3. Rosenbaum E., Partin A., Eisenberger M.A. Biochemical relapse after primary treatment for prostate cancer: studies on natural history and therapeutic considerations. J Natl Compr Canc Netw 2004;2: 249–56.
4. Stephenson A.J., Scardino P.T., Bianco F.J., Eastham J.A. Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy. Curr Treat Options Oncol 2004;5:357–65.
5. Chade D.C., Shariat S.F., Cronin A.M. et al. Salvage radical prostatectomy for radiationrecurrent prostate cancer: a multi-institutional collaboration. Eur Urol 2011;60:205–10.
6. Chade D.C., Eastham J., Graefen M. et al. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol 2012;61:961–71.
7. Falcone M., Rolle L., Ceruti C. et al. Prospective analysis of the surgical outcomes and patients' satisfaction rate after the AMS Spectra penile prosthesis implantation.Urology 2013;82(2):373–6.
8. Picchio M., Briganti A., Fanti S. et al. The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur Urol 2011;59: 51–60.
9. Scattoni V., Picchio M., Suardi N. et al. Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol 2007;52:423–9.
10. Rigatti P., Suardi N., Briganti A. et al. Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C] choline positron emission tomography/ computed tomography. Eur Urol 2011;60: 935–43.
11. Van der Aa А., Drake M.J., Kasyan G.R. et al. The Artificial Urinary Sphincter After a Quarter of a Century: a critical systematic review of its use in male non-neurogenic incontinence. Eur Urol 2013;63: 681–9.
Review
For citations:
Veliev E.I., Golubtsova E.N., Tomilov A.A. Surgical treatment for progressive prostate cancer: A clinical case. Cancer Urology. 2014;10(3):95-99. (In Russ.) https://doi.org/10.17650/1726-9776-2014-10-3-95-99
Views:
661
Email this article 